Acta pharmacologica Sinica · 2026
The multilevel exploration test, a novel paradigm to measure exploratory behavior in depression animal models and the involvement of the PL-ZI circuit.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xu Jun-Nan, Li Jing-Ting, Xu Ru-Xia, Wang Yun-Feng, Gao He-Wei, He Hao-Tian, Guo Han, Liang Yu, Zhu Yong-Dan, Li Xiao-Wen, Yang Jian-Ming, Li Xiao-Ming, Chen Yi-Hua, Gao Tian-Ming
Аннотация
Diminished drive is one of the core symptoms of major depressive disorder (MDD) diagnosis, yet its underlying neural mechanisms remain elusive, primarily due to a lack of appropriate animal models. We developed a novel Multilevel Exploration Test (MET) apparatus to evaluate exploratory behavior, which is captured as a dynamic, stage-dependent process involving "search", "attend/investigate", and "approach" phases. We employed fiber photometry to measure real-time dopamine dynamics in the nucleus accumbens. We further combined cFos staining and neural circuit tracing to identify relevant brain regions and circuits, and employed chemogenetics to selectively modulate prelimbic cortex (PL) inputs to zona incerta (ZI). The MET tests were conducted across five depression models, with ketamine administration to evaluate rescue effects. Machine learning algorithms were utilized to analyze MET data and predict individual emotional states (normal, anxiety-like, depression-like). Here, we developed a novel paradigm to assess exploratory behavior, which demonstrates etiological validity, face validity and predictive validity. Depressed mice exhibited reduced motivation for exploration in this paradigm, while stimulation of the PL-ZI circuit not only restored exploratory deficits but also alleviated other depression-like behaviors in these mice. Furthermore, we established a machine learning-based model to predict individual animals' emotional states by integrating data from the new paradigm, achieving a prediction accuracy of over 92%. The MET provides a functional, high-throughput paradigm for dissecting motivation-related pathology. It facilitates the assessment of depressive-like behaviors, enables the prediction of emotional states, and supports the discovery of novel targets for antidepressant development.